Reveal LINQ Respiration Clinical Study
Sponsored by Medtronic Cardiac Rhythm and Heart Failure
About this trial
Last updated 3 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 4 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Patient is ≥ 55 years old
- Patient (or patient's legally authorized representative) is willing and able to provide written informed consent
- Patient is willing and able to comply with the study procedures
- Patient has an active Medtronic Reveal LINQ device that has been implanted for ≥ 60 days and no more than 3 years
Exclusion Criteria
- Patient has an existing condition that necessitates the use of supplemental oxygen
- Patient has an active acute respiratory infection or a respiratory disorder that may affect ability to perform respiratory maneuvers
- Patient has NYHA Class IV heart failure per most recent assessment
- Any concomitant condition that might endanger the patient through participation in the study or interfere with study procedures, as assessed by the investigator
- Patient is enrolled in another study that could confound the results of this study
- Patient has an existing implantation of Medtronic IPG, ICD, CRT-D or CRT-P device